Arbutus Biopharma Corporation
ABUS
$3.59
$0.010.28%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -12.97% | -8.09% | -4.05% | -10.00% | 9.86% |
Total Receivables | -18.60% | -48.98% | 41.98% | -7.69% | -24.53% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 43.66% | 37.05% | -35.48% | -26.21% | 7.04% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -11.72% | -8.25% | -4.11% | -10.42% | 9.09% |
|
|||||
Total Current Assets | -11.72% | -8.25% | -4.11% | -10.42% | 9.09% |
Net Property, Plant & Equipment | -11.90% | -96.14% | -7.30% | -11.25% | -7.75% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | 0.00% | -- | -- | -- |
Total Assets | -11.75% | -11.16% | -6.22% | -12.25% | 6.49% |
|
|||||
Total Accounts Payable | -41.03% | -3.28% | 0.04% | -12.71% | -29.15% |
Total Accrued Expenses | -38.04% | -25.61% | 12.52% | -44.84% | 87.74% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -8.70% | 16.56% | 3.21% | 3.31% | -9.76% |
Total Finance Division Other Current Liabilities | -93.96% | 68.06% | -34.03% | 4.01% | -4.44% |
Total Other Current Liabilities | -93.96% | 68.06% | -34.03% | 4.01% | -4.44% |
Total Current Liabilities | -74.15% | 24.41% | -17.47% | -16.25% | 11.33% |
|
|||||
Total Current Liabilities | -74.15% | 24.41% | -17.47% | -16.25% | 11.33% |
Long-Term Debt | -11.32% | -8.70% | -9.14% | -9.28% | -8.40% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -8.15% | -22.33% | -17.59% | -14.51% | -3.13% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -19.44% | 2.28% | 57.02% | 4.30% | 2.71% |
Total Liabilities | -46.40% | 10.23% | 2.35% | -10.74% | 5.43% |
|
|||||
Common Stock & APIC | 0.09% | 0.43% | 0.21% | 0.26% | 1.89% |
Retained Earnings | 0.18% | -1.82% | -0.94% | -1.50% | -1.53% |
Treasury Stock & Other | -0.04% | -0.06% | -0.09% | 0.45% | 0.13% |
Total Common Equity | 4.82% | -18.70% | -8.91% | -12.71% | 6.82% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 4.82% | -18.70% | -8.91% | -12.71% | 6.82% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 4.82% | -18.70% | -8.91% | -12.71% | 6.82% |
|